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Persistent polypharmacy and fall injury risk:
the Health, Aging and Body Composition Study
Lingshu Xue1,2, Robert M. Boudreau1, Julie M. Donohue2, Janice C. Zgibor3, Zachary A. Marcum4,
Tina Costacou1, Anne B. Newman1, Teresa M. Waters5 and Elsa S. Strotmeyer1*

Abstract
Background: Older adults receive treatment for fall injuries in both inpatient and outpatient settings. The effect of
persistent polypharmacy (i.e. using multiple medications over a long period) on fall injuries is understudied, particularly for outpatient injuries. We examined the association between persistent polypharmacy and treated fall injury risk
from inpatient and outpatient settings in community-dwelling older adults.
Methods: The Health, Aging and Body Composition Study included 1764 community-dwelling adults (age
73.6 ± 2.9 years; 52% women; 38% black) with Medicare Fee-For-Service (FFS) claims at or within 6 months after
1998/99 clinic visit. Incident fall injuries (N = 545 in 4.6 ± 2.9 years) were defined as the initial claim with an ICD-9 fall
E-code and non-fracture injury, or fracture code with/without a fall code from 1998/99 clinic visit to 12/31/08. Those
without fall injury (N = 1219) were followed for 8.1 ± 2.6 years. Stepwise Cox models of fall injury risk with a time-varying variable for persistent polypharmacy (defined as ≥6 prescription medications at the two most recent consecutive
clinic visits) were adjusted for demographics, lifestyle characteristics, chronic conditions, and functional ability. Sensitivity analyses explored if persistent polypharmacy both with and without fall risk increasing drugs (FRID) use were
similarly associated with fall injury risk.
Results: Among 1764 participants, 636 (36%) had persistent polypharmacy over the follow-up period, and 1128
(64%) did not. Fall injury incidence was 38 per 1000 person-years. Persistent polypharmacy increased fall injury risk
(hazard ratio [HR]: 1.31 [1.06, 1.63]) after adjusting for covariates. Persistent polypharmacy with FRID use was associated with a 48% increase in fall injury risk (95%CI: 1.10, 2.00) vs. those who had non-persistent polypharmacy without
FRID use. Risks for persistent polypharmacy without FRID use (HR: 1.22 [0.93, 1.60]) and non-persistent polypharmacy
with FRID use (HR: 1.08 [0.77, 1.51]) did not significantly increase compared to non-persistent polypharmacy without
FRID use.
Conclusions: Persistent polypharmacy, particularly combined with FRID use, was associated with increased risk for
treated fall injuries from inpatient and outpatient settings. Clinicians may need to consider medication management
for FRID and other fall prevention strategies in community-dwelling older adults with persistent polypharmacy to
reduce fall injury risk.
Keywords: Persistent polypharmacy, Treated fall injury, Medicare, Medication, Falls, FRID, Geriatrics
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Background
Medication use may be associated with falls and fall injuries among older adults. Nearly one third of communitydwelling U.S. adults over 65 years old experience falls
annually, with the percent increasing to 50% in adults

© The Author(s) 2021. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which
permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the
original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or
other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line
to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory
regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this
licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativeco
mmons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Xue et al. BMC Geriatrics

(2021) 21:710

over 80 years old [1, 2]. Of those who fall, 5% incur serious injuries such as fractures, joint dislocation, and
head trauma [3]. Each year, nearly 3 million older adults
receive treatment for fall injuries in emergency departments (ED), and around 800,000 are hospitalized for fall
injuries [4]. In the US, fall injuries resulted in approximately $668 billion in medical expenses during 2015 [5].
One potentially modifiable risk factor for fall injury is
multiple medication use, commonly referred to as polypharmacy [6]. In previous studies related to fall injury,
polypharmacy has been defined according to the number of medications measured in a single short period (e.g.
90 days) [7–9]. However, older adults may vary in use of
medications over time [10, 11]. Newly diagnosed acute or
chronic conditions may prompt an increase in the number of medications, while deprescribing and poor adherence may reduce the number [11]. Considering whether
polypharmacy was persistent or transient over time may
be important to identify older adults at high risk of fall
injury.
The role of persistent polypharmacy in fall injury
remains largely unexamined. In a few previous studies based on claims data, persistent polypharmacy was
defined as use of multiple medications for more than
6 months in a year follow-up; however many older adults
have polypharmacy for longer duration and additionally these studies did not consider fall injury risks [12,
13]. Studies examining polypharmacy persisting longer
than 1 year are strongly needed. One study of adults
aged 60-64 years found that polypharmacy at two time
points 5 years apart doubled the decline in chair rise
speed compared to polypharmacy only at one time point
[14], suggesting persistent polypharmacy for more than
1 year may be associated with reduced physical function. However, this study did not account for comorbid
conditions or factors related to physical function in the
analysis, and did not investigate fall injury outcomes
[14]. To fill this gap, our study defined persistent polypharmacy as use of multiple medications in two consecutive years based on our previous studies in this cohort
[15, 16], and examined its association with fall injury. In
addition, fall-risk increasing drugs (FRID, i.e. sedatives
and hypnotics, neuroleptics and antipsychotics, antidepressants, benzodiazepines, and opioids) specifically
appear to be strongly related to fall injuries rather than
polypharmacy alone [17–19]. Whether persistent polypharmacy with FRID use is associated with a higher fall
injury risk compared to polypharmacy without FRID use
has not been well investigated. Understanding the role
of persistent polypharmacy in fall injury is important for
evaluating the appropriateness of deprescribing and providing a tailored intervention to reduce fall injury risk in
older adults. Therefore, our objective was to determine

Page 2 of 10

whether persistent polypharmacy, both with and without
FRID use, is associated with an increased risk of fall injuries treated in inpatient and outpatient settings among
community-dwelling older adults with Medicare Fee-forservice (FFS).

Methods
Study design and participants

The Health, Aging and Body Composition (Health ABC)
Study is a prospective cohort study designed to investigate if changes in body composition act as a common
pathway by which multiple diseases affect morbidity,
disability, and risk of mortality in community-dwelling
older adults [20]. This study included 3075 participants
(48.4% male, 41.6% black) aged 70–79 years at baseline
(1997/1998) [20]. They were recruited from a random
sample of Medicare beneficiaries in Memphis, Tennessee (TN), and Pittsburgh, Pennsylvania (PA), and all ageeligible black community residents in these areas [21].
Participants were excluded if they: 1) reported difficulty
with walking one-quarter of a mile or climbing 10 steps
without resting, or difficulty with performing mobilityrelated activities of daily living; 2) had life-threatening
cancers and received active treatment in the past 3 years;
or 3) had plans of leaving the area within 3 years [21]. The
institutional review boards at the participating institutions approved the study protocol, and written informed
consent was obtained before testing and data collection
[21]. The exclusion criteria for this analysis included 1)
missing a 2000/01 clinic visit (N = 671) since Medicare
data was only linked for those participants; 2) lacking
linked Medicare FFS Parts A and B claim data (N = 28);
3) not having FFS coverage at 1997/98 baseline clinic
visit (N = 456) or within 6 months after the baseline visit
(N = 20); and 4) having fall injury (N = 90) or ending FFS
coverage (N = 46) before 1998/99 clinic visit when persistent polypharmacy was measured (Fig. 1). After exclusions, the analytic sample included 1764 participants.
Primary independent variables

The primary independent variable was a time-varying
indicator of persistent polypharmacy. We defined persistent polypharmacy as use of ≥6 prescription medications
at both of the two most recent consecutive annual clinic
visits based on the established Health ABC definition
for the long-term use of fall-related medications [6, 15].
Compared to some definitions for polypharmacy, which
define it as ≥5 medications in short periods, we used a
cut-point of ≥6 medications due to known increase in
the number of medications taken as age increases, especially considering that polypharmacy was measured as
time-varying in our cohort with more than 8 years follow-up. Non-persistent polypharmacy was defined as use
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Fig. 1 Flow chart displaying selection of study participants for analysis. FFS: Fee-For-Service

of ≥6 medications only at one visit or use of <6 medications at both of the two most recent consecutive visits.
Participants with intermittent polypharmacy (i.e. using
≥6 medications at some clinic visits but never having
persistent polypharmacy during the entire study period,
N = 174) were included only in the sensitivity analyses to
distinguish the effect of persistent polypharmacy from
that of polypharmacy at a single time point. FRID include
antiepileptic drugs, hypnotics/sedatives drugs, antipsychotics, antidepressants, benzodiazepines, and opioids
based on previous reviews for FRID and the 2015 updates
of the Beers’ criteria (supplementary Table S1) [17–19].
Antihypertensives and anticholinergic drugs (except for
antidepressants and antipsychotics) were not included
due to non-significant association with fall risk shown
in previous published papers in the Health ABC Study
[16, 22]. A time-varying FRID use indicator was created
for sensitivity analyses based on if participants used ≥1
FRID at most recent (short-term) or both (long-term)
of the two most recent consecutive visits since a previous publication in our study showed both short-term and
long-term use of FRID were related to increased fall risk
[15] (Fig. 2).
Medication information was collected at clinic visits in
1997/98, 1998/99, 1999/2000, 2001/02, 2002/03, 2004/05,
2006/07, and 2007/08 and coded according to the Iowa
Drug Information System [23]. Participants brought
all medications taken during the 2 weeks before the
clinic visit. Trained researchers transcribed medication

information from the containers. Non-prescription
medications such as over-the-counter medications,
and herbal and dietary supplements are not commonly
included in the definition of polypharmacy [6] so we did
not include these. Since medication information was not
collected in 2000/01, 2003/04, and 2005/06, we used the
method of last observation carried forward (LOCF) to
estimate the missing data. Sensitivity analyses also were
conducted in the data without the estimation by LOCF.
Outcome measure

The primary outcome was incident treated fall injury
from the 1998/99 clinic visit to 12/31/08, identified using
Fee-for-Service (FFS) Part A and Part B Medicare claim
datasets which included inpatient, outpatient, physician/supplier, and carrier (claims from non-institutional
providers) files [21]. The Medicare claims allowed fall
injury events treated in inpatient and outpatient settings
(e.g. inpatient hospitals, outpatient clinics, and emergency departments) to be collected if participants did
not attend clinic visits or provide self-report data [21].
ICD-9 E-codes (E880-888) which describe the “mechanism of injury” were used to ascertain falls, and ICD-9
billing codes were used to identify injuries and fractures
[21]. Incident fall injury was defined as the first event
with 1) an ICD-9 fall E-code (E880-888) and non-fracture
injury, 2) a vertebral fracture code (805-806) with a fall
E-code, or 3) a non-vertebral fracture code (800-804,
807-829) with/without a fall E-code [21]. We excluded all
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Fig. 2 Timeline and illustrations for persistent polypharmacy. PP: persistent polypharmacy. FRID: fall risk increasing drugs

traumatic injuries (e.g., motor vehicle accidents), intentional injuries, and pathologic injuries [21]. We compared
a subset of Medicare fall injuries to the self-reported fall
injuries with medical records to validate our diagnoses
code algorithm which showed excellent agreement with
the medical records [21]. We excluded vertebral fractures
without fall codes in our algorithm since only 50% of vertebral fractures in Medicare claims were fall-related when
validated with medical records [21]. Participants were
followed until the first occurrence of a fall injury, the end
of FFS coverage, loss to follow-up, death, or through the
end of 2008 when Medicare claims were last collected for
the study.
Covariates

All covariates were measured at the 1997/98 clinic visit
unless noted otherwise. Self-reported demographic variables included age, sex, race (white or black), education
(<high school (HS), HS graduate, or postsecondary),
and study site (Memphis or Pittsburgh) [21]. Height was
measured using a stadiometer and weight was measured
on a calibrated balance beam scale [21]. The baseline
BMI was calculated using the formula of weight (kilograms) divided by height (meters) squared [21]. Lifestyle
factors included alcohol consumption (> 1 drink/week),
self-reported physical activity (kcal/kg per week spent
walking, climbing stairs, and exercise), and self-reported
smoking status (current, past, never; at the 1999/2000
clinic visit) [24].

Participants self-reported cardiovascular disease (i.e.
bypass or coronary artery bypass graft, carotid endarterectomy, myocardial infarction, angina pectoris, or congestive heart failure), cerebrovascular disease (i.e. stroke
or transient ischemic attack), poor vision (poor eyesight, cataract, glaucoma, retinal disease, and/or macular
degeneration), history of falls, knee pain for > 1 month,
and leg pain when walking. We defined diabetes as selfreported physician diagnosis, use of hypoglycemic medication, or fasting glucose ≥126 mg/dL (47.0 mmol/L)
after an 8-h fast [25]. Diagnosed and/or treated hypertension (“hypertension” hereafter) was defined through
a study-based definition as self-reported hypertension
with use of any antihypertensive medications, or sitting systolic blood pressure ≥ 140 mmHg or/and sitting
diastolic blood pressure ≥ 90 mmHg [21, 22]. Depressive
symptoms were assessed based on the Center for Epidemiologic Studies Depression Scale (CES-D) [26]. Cognitive function was measured by the Modified Mini-Mental
State Examination (3MSE) score [27]. Poor renal function
was defined as cystatin C level > 1 mg/dL [28]. Sensory
nerve impairment was defined as insensitivity to 1.4-g
monofilament at the 2000/01 clinic visit [29]. We also
included physical performance as 6-m usual gait speed
[30].
Statistical analyses

We compared baseline characteristics for those with vs.
without fall injury using t-tests for normally distributed
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variables, Wilcoxon rank-sum tests for non-normally distributed variables, and Chi-squared tests for categorical
variables. Because the status of persistent polypharmacy
varied over time, we reported the event rate of persistent polypharmacy in the follow-up as well as fall injury
incidence rates in the periods of persistent polypharmacy
and non-persistent polypharmacy. We also included the
indicators of persistent polypharmacy as a time-varying
predictor in multivariable Cox proportional hazards
(Cox PH) regression to estimate fall injury risk from the
1998/99 clinic visit. Baseline covariates described above
were time-independent and added to the model in a
stepwise manner. To minimize collinearity, additional
covariates except for age, sex, and race were subsequently
removed at a P > 0.10 and if the effect of persistent polypharmacy was not modified > 10% [31]. In sensitivity
analyses, we included a combination time-varying variable for persistent polypharmacy with and without FRID
use in models, defined as: persistent polypharmacy with
FRID use; persistent polypharmacy without FRID use;
non-persistent polypharmacy with FRID use; non-persistent polypharmacy without FRID use [19]. Analyses were
done in the cohort including 174 participants with intermittent polypharmacy (N = 1764). In addition to the cutpoint of 6 medications in the primary analyses, we used 2
to 5 and 7 to 10 as alternative cut-points to define persistent polypharmacy (e.g. ≥2 vs. < 2 medication, ≥3 vs. < 3
medications, ≥4 vs. < 4 medications, ≥5 vs. < 5 medications, etc.) and repeated the analyses [7–9]. All analyses
were repeated without LOCF to check for consistency
of results. No violation of PH assumption was detected.
Analyses were performed using SAS, version 9.4 (SAS
Institute, Inc., Cary, NC).

Results
At the 1997/98 clinic visit, participants were aged
73.6 ± 2.9 years, 53% were women, and 37% were black.
In the analytic sample (N = 1764), participants were followed for 8.0 ± 3.1 years from the 1998/99 clinic visit.
Among 1764 participants, 36% (N = 636) had persistent
polypharmacy, and 64% (N = 1128) did not. The rate
of persistent polypharmacy was 179 events per 1000
person-years. Incident fall injuries occurred in 31% of
1764 participants (N = 545, 414 fracture and 131 nonfracture) over 4.6 ± 2.9 years following the 1998/99 clinic
visit. Those without fall injury (N = 1219) were followed
for 8.1 ± 2.6 years. The incident rate of fall injury was
38 per 1000 person-years in the follow-up, with 50 per
1000 person-year during the period of persistent polypharmacy, and 36 per 1000 person-year during the period
of non-persistent polypharmacy. Participants with fall
injury were older and more likely to be women, white,
and a high school graduate compared to those without
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fall injury (Table 1). Participants with fall injuries were
more likely to have lower BMI, higher 3MSE scores, and
self-report a fall in the past 12 months. No difference
was found between those with and without fall injuries

Table 1 Baseline characteristics and medication use over time
by incident fall injury status (N = 1764)
Characteristics, Mean ± SD or
N (%)

Fall injury (N = 545)

No Fall
injury
(N = 1219)

Women, N (%)

357 (65.5%)b

73.9 ± 3.0a

73.5 ± 2.8

Black race, N (%)

154 (28.3%)b

508 (41.7%)

Pittsburgh site, N (%)

243 (44.6%)a

464 (38.1%)

Age, years

Body mass index, kg/m

2

Current smoker, N (%)

b

26.7 ± 4.8

561 (46.0%)

27.5 ± 4.7

39 (7.2%)

116 (9.5%)

Alcohol > 1 drink/week, N (%)

257 (47.9%)

609 (50.7%)

≥ High school graduate, N (%)

440 (81.6%)b

872 (72.4%)

Fall history, N (%)

144 (26.6%)a

242 (19.9%)

Hypertension, N (%)

311 (57.0%)

695 (57.1%)

Cardiovascular disease, n (%)

91 (16.9%)

208 (17.3%)

Cerebrovascular disease, n (%)

45 (8.3%)

78 (6.5%)

Diabetes, N (%)

107 (19.7%)

264 (21.8%)

Cystatin C > 1.0, N (%)

236 (44.0%)

556 (46.0%)

Poor vision, N (%)

12 (2.2%)

25 (2.1%)

CES-D score

4.6 ± 5.2

4.5 ± 5.2

181 (33.3%)

379 (31.2%)

1.4 g Monofilament insensitivity,
N (%)

207 (38.8%)

421 (35.1%)

6-m Gait speed, m/second

1.2 ± 0.2

1.2 ± 0.2

3.5 ± 2.7a

3.0 ± 2.6

4.3 ± 3.1b

3.7 ± 2.7

3MSE score
Knee or leg pain, N (%)

Number of medications
1998/99 clinic visit
1999/00 clinic visit
2001/02 clinic visit
2002/03 clinic visit
2004/05 clinic visit
2006/07 clinic visit
2007/08 clinic visit
Use of ≥1 FRID, N (%)

91.7 ± 6.9b

90.3 ± 8.1

3.7 ± 2.9b

3.3 ± 2.7

4.5 ± 3.2b

4.0 ± 2.9

5.1 ± 3.3a

4.6 ± 3.2

5.7 ± 3.3a

5.0 ± 3.5

5.9 ± 3.7a

5.3 ± 3.6

1998/99 clinic visit

126 (23.1%)b

201 (16.5%)

1999/00 clinic visit

142 (26.0%)b

220 (18.1%)

2001/02 clinic visit

157 (28.8%)b

252 (20.7%)

2002/03 clinic visit

158 (29.0%)b

270 (22.1%)

2004/05 clinic visit

122 (22.4%)b

232 (19.0%)

2006/07 clinic visit

109 (20.0%)

b

2007/08 clinic visit

102 (18.7%)b

211(17.3%)
196 (16.1%)

CES-D Center for Epidemiologic Studies Depression Scale score, range is 0 to
60; a score of 16 points or more is considered depressed, 3MSE Modified MiniMental State Examination, range is 0 to 100; lower scores represent lower levels
of mental competency, FRID Fall risk increasing drugs
a

P < 0.05, b < 0.01 for fall injury vs. no fall injury
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for diabetes, cardiovascular disease, cerebrovascular disease, CES-D scores, poor vision, knee or leg pain, gait
speed, 1.4-g monofilament insensitivity, or cystatin C
level > 1 mg/dL. No differences were seen in the results
of descriptive analyses between the samples including
(N = 1764) and excluding those with intermittent polypharmacy (N = 1590).
In the univariate Cox model, participants with persistent polypharmacy had an increased fall injury risk than
those with non-persistent polypharmacy (HR: 1.29 [1.05,
1.59]). After adjusting for age, sex, race, study site, alcohol use, BMI, 1.4-g monofilament insensitivity, fall history, the HR of persistent polypharmacy was 1.31 (1.06,
1.63) (Table 2). Compared to participants who had nonpersistent polypharmacy without FRID use, those with
persistent polypharmacy and FRID use had a significantly
increased fall injury risk (HR: 1.48 [1.10, 2.00]). Compared to non-persistent polypharmacy without FRID use,
HRs for persistent polypharmacy without FRID use (HR:
1.22 [0.93, 1.60]) and non-persistent polypharmacy with
FRID use (HR: 1.08 [0.77, 1.51] did not show an association with fall injury risk. Results of sensitivity analyses
were consistent with the primary analyses after including those with intermittent polypharmacy in the referent
group (Supplementary Table S2). Most of the results were
consistent with the primary analyses when cut-points of
7 to 10 medications were used to define persistent polypharmacy. In addition, there was also a noticeable jump
in the HR for fall injury when going from a cut-point of
5 to a cut-point of 6. This finding supports the criteria of
6 prescription medications as an appropriate cut-point

to distinguish the effect of persistent polypharmacy [6].
(Supplementary Table S3). The results without LOCF
were consistent with primary analyses (Supplementary
Table S2).

Discussion
In this prospective study of community-dwelling older
adults with Medicare FFS, we found an increased risk of
treated fall injury with persistent polypharmacy, particularly when combined with use of FRID. In our findings,
older adults with persistent polypharmacy and FRID use
had nearly 50% higher fall injury risk compared to those
who had non-persistent polypharmacy without FRID
use. To our knowledge, our study was the first to suggest
a synergic effect of polypharmacy and FRID on the risk
of fall injuries treated in both inpatient and outpatient
settings.
The contribution of FRID use to the association of persistent polypharmacy and fall injury risk has not been
well investigated. Previous studies in community-dwelling older adults showed that polypharmacy was associated with inpatient treated fall injuries after accounting
for the confounding effect of FRID, but did not report
the contribution of FRID use to the association [9, 32,
33]. However, our study observed a possible synergic
effect from polypharmacy and FRID use on fall injury
risk. The varying definitions for FRID use makes it difficult to compare across previous work and is a limitation
in the field. Our FRID definition was modified based on
the Beer’s Criteria commonly used in the US [17–19];
while previous studies used medication lists from their

Table 2 Adjusted hazard ratios of persistent polypharmacy and FRID on fall injury in the primary analysis
Model 1

PP vs. non-PP

Model 2

HR (95% CI)

p-value

1.31(1.06,1.63)

0.014

HR (95% CI)

p-value

Joint-effect of PP and FRID use (reference: Non-PP without FRID use)
PP with FRID use

1.48(1.10,2.00)

0.010

PP without FRID use

1.22(0.93,1.60)

0.155

1.08(0.77,1.51)

0.659

0.98(0.96,1.00)

0.061

Non-PP with FRID use
Body mass index, per 1 kg/m2

0.98(0.96,1.00)

0.060

Age, per 1 year

1.03(1.00,1.07)

0.046

1.03(1.00,1.07)

0.048

Women vs. men

2.09(1.71,2.56)

<.0001

2.08(1.70,2.54)

<.0001

Blacks vs. whites

0.64(0.51,0.79)

<.0001

0.64(0.51,0.80)

<.0001

Pittsburgh site vs. Memphis site

1.54(1.27,1.87)

<.0001

1.55(1.27,1.88)

<.0001

Fall history vs. no history

1.29(1.05,1.59)

0.015

1.29(1.05,1.59)

0.017

1.4 g Monofilament insensitivity

1.22(1.01,1.47)

0.040

1.22(1.01,1.47)

0.042

Education (<high school (HS), HS graduate, or postsecondary), self-reported physical activity (kcal/kg per week spent walking, climbing stairs and exercise), selfreported smoking status (current, past, never), alcohol > 1 drink/week, self-reported cardiovascular diseases, poor vision, knee pain for > 1 month, leg pain when
walking, diagnosed and/or treated hypertension and diabetes, CES-D score, Modified Mini-Mental State Examination (3MSE) scores, cystatin C level > 1 mg/dL, gait
speed over 6 m were added to the model in a stepwise manner and subsequently removed at a P > 0.10
FRID Fall risk increasing drugs, PP Persistent polypharmacy
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national fall prevention guidelines or STOPP/Fall criteria
which is widely used in European countries [9, 32–34].
Our definition was tailored to the Health ABC population, excluding antihypertensives and some anticholinergics due to non-significant association with fall risk
shown in previous published Health ABC findings [16,
22]. The other major difference in our study vs. previous
studies is the inclusion of outpatient fall injuries (i.e. falls
and fall injuries treated in outpatient clinics, emergency
departments, or other outpatient settings) which are estimated to constitute around 57% of fall injuries requiring
medical care [35]. Our results may suggest older adults
with polypharmacy and FRID use were at higher risk of
fall injuries leading to treatment in outpatient settings in
addition to inpatient hospital settings [9, 32, 36]. Future
studies need to carefully consider the appropriateness of
certain medication classes in the FRID definition for their
populations, as no standard definition exists.
Persistent polypharmacy is most likely the consequence
of chronic multi-morbidities [36, 37]. Older adults with
multi-morbidities may be more likely to receive any
treatment, which could increase the likelihood of receiving treatment for fall injuries as well, especially for less
severe injuries [38, 39]. In addition, older adults with
multi-morbidities who also use FRID may experience
increased fall risks related to chronic conditions such as
osteoarthritis, vision loss, and peripheral nerve impairment [40–42], as well as from effects of FRID use such
as sedation, dizziness, and postural sway [15, 43–45]. The
adverse effects of FRID use may be more likely in older
adults with multi-morbidities and/or polypharmacy possibly due to increasing pharmacodynamic sensitivity to
FRID or high risk of drug-drug interactions [15, 43]. Further studies are needed to replicate our findings in other
samples of older adults to assess the joint effect of polypharmacy and FRID use in fall injury.
A growing number of observational studies, including
our study, showed polypharmacy appears to be a risk factor for fall injury in community-dwelling older adults [9,
32, 44]. Interventions are needed to reduce the risk for
fall injuries in older adults with polypharmacy living in
the community. However, several randomized trials demonstrated that single intervention targeting withdrawing medications, including FRID use, did not reduce fall
injury risk significantly among older adults [46, 47]. Discrepant results between observational studies and randomized trials possibly suggest that single intervention for
medications is insufficient for reducing fall risk as observational studies are not able to account for unmeasured
factors, such as the severity of chronic conditions that is
correlated with polypharmacy and increases fall injuries
as well. In addition, previous randomized trials showed
the difficulty of implementing medication withdrawal
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interventions among older adults using multiple medications [48, 49]. Besides medication withdrawal interventions, other evidence-based recommendations for fall
prevention include exercise and multifaceted interventions which are customized based on initial assessments
in various components, such as balance, gait, vision, postural blood pressure, medication, environment, cognition, and psychological health [50]. Studies have shown
that community-dwelling older adults who present in
ED with a fall often did not receive fall risk assessment
and relevant interventions in accordance with guidelines, representing a missed opportunity to address their
fall risk profile [51, 52]. Some randomized trials further
supported that customized fall prevention interventions including medication management initiated in ED
services reduced the risk of subsequent fall injuries by
43-65% [53, 54]. Therefore, clinicians in outpatient settings, especially in ED may need to consider tailoring
fall prevention strategies in multiple aspects, in addition
to medication management for community older adults
with polypharmacy, such as promoting exercise, wearing
safe shoes, improving safety in the home environment,
and additional preventative efforts related to chronic
multi-morbidities (e.g. diabetes, cardiovascular diseases,
and dementia).
Tailoring fall interventions by demographic groups
may need to be considered in clinical practice to improve
the effectiveness of fall prevention. Our study, in accordance with previous studies, demonstrated that women
and White individuals were more likely to have fall injuries compared to men and Black individuals, respectively
[55–58]. Sex differences in fall injury risk, especially
higher fracture risk in women, are well-established [55,
59]. Racial differences in fall injury risk may reflect differences in chronic diseases in late life, such as higher
prevalence of osteoporosis in older White populations
[60]. In our population, education level was not associated with risk of fall injury after adjusting for race in the
final model, suggesting race group explained the association of education level and fall injury. Further studies are
needed to delineate the underlying mechanisms for lower
fall injury risk in non-White older adults and evaluate the
effectiveness of fall interventions in racially diverse aging
populations of men and women.
Our study has several strengths. A follow-up for
nearly 8 years allowed examining of the temporal
relationship between polypharmacy and incident fall
injuries. The combined variable of persistent polypharmacy and FRID use over time may improve our
understandings of the role of FRID in the relationship between polypharmacy and fall injury risk. Our
focus on persistent polypharmacy may provide more
comprehensive insights of real-life medication use
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compared to previous studies that focused on polypharmacy at a single time point [9, 32, 61]. Our medication inventory was based on participants’ use rather
than prescription fill or pharmacy databases which
may be less accurate for actual use. We used a validated aggregate diagnoses code algorithm to identify
treated fall injuries in both inpatient and outpatient
settings compared to previous studies including only
inpatient fall injuries based on hospital admissions [8,
9, 32]. In addition, our participants had more chronic
conditions and a higher prevalence and incidence of
fall injury compared to older adults ≤70 years old [62],
allowing us to study older adults at high risk for both
polypharmacy and fall injuries. Moreover, the cohort
study data combined with Medicare FFS claims enabled us to adjust for a rich set of health conditions
and factors compared to other studies that only used
claims-based covariates.
A limitation of our study is that medication inventories were done annually though not done at certain clinic visits and the LOCF method was used to
estimate the missing data from annual visits. The
prevalence of persistent polypharmacy may be overestimated since LOCF may misclassify those without
persistent polypharmacy as with persistent polypharmacy. Imputation of medication use is not an ideal
approach in older populations due to the relationship
of missing data at clinic visits and poor health status
[63]. However, our results showed no changes when
analyzing the data without LOCF. Annual medication
inventories did not allow us to address non-adherence
issues which are prevalent among older adults with
polypharmacy [64]. The fall injuries in our study were
medically treated; therefore, less serious, non-treated
fall injuries were not ascertained. We also could not
observe complete claims for those with dual eligibility for Medicaid and/or veteran affairs health insurance. Thus, the rate of treated fall injury events may
be underestimated. Our results should be reevaluated
in non-PA or TN residents since reporting E-code
may not be mandatory in some states [21]. Finally, our
population is community-dwelling older adults with
Medicare FFS eligibility who met the inclusion criteria
of the Health ABC cohort and had at least two clinic
visits to measure persistent polypharmacy. These
inclusion criteria likely resulted in a healthier cohort
compared to the general Medicare FFS population
since those missing clinic visits generally had older
age, more mobility limitation, and more cognitive
impairment [63]. Also, our results may be not representative of older adults with other health care coverage or in non-community based settings such as skilled
nursing facility (SNF) settings.
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Conclusions
Our study showed persistent polypharmacy was associated with increased fall injury risk treated in both inpatient and outpatient settings, particularly when combined
with FRID use. These findings suggest that future studies
should consider targeting medication use such as FRID
use and other fall prevention efforts, such as altering
behaviors or living environment, and tailoring interventions by sex and racial groups in older adults with persistent polypharmacy to decrease treated fall injuries not
only in inpatient but also in outpatient settings.
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